205 related articles for article (PubMed ID: 25991914)
1. Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: a photodynamic therapy for atherosclerosis.
Spyropoulos-Antonakakis N; Sarantopoulou E; Trohopoulos PN; Stefi AL; Kollia Z; Gavriil VE; Bourkoula A; Petrou PS; Kakabakos S; Semashko VV; Nizamutdinov AS; Cefalas AC
Nanoscale Res Lett; 2015; 10():210. PubMed ID: 25991914
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells.
Jiang Z; Ye J; Yang J; Wang J; Jia L; Ho RJ
Curr Cancer Drug Targets; 2019; 19(4):312-320. PubMed ID: 29984658
[TBL] [Abstract][Full Text] [Related]
4. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
[TBL] [Abstract][Full Text] [Related]
5. Nanoscaled PAMAM Dendrimer Spacer Improved the Photothermal-Photodynamic Treatment Efficiency of Photosensitizer-Decorated Confeito-Like Gold Nanoparticles for Cancer Therapy.
Saw WS; Anasamy T; Do TTA; Lee HB; Chee CF; Isci U; Misran M; Dumoulin F; Chong WY; Kiew LV; Imae T; Chung LY
Macromol Biosci; 2022 Aug; 22(8):e2200130. PubMed ID: 35579182
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
10. Heparosan-based self-assembled nanocarrier for zinc(II) phthalocyanine for use in photodynamic cancer therapy.
Zha Z; Miao Y; Tang H; Herrera-Balandrano DD; Yin H; Wang SY
Int J Biol Macromol; 2022 Oct; 219():31-43. PubMed ID: 35926671
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
Broekgaarden M; de Kroon AI; Gulik TM; Heger M
Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
[TBL] [Abstract][Full Text] [Related]
12. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity.
Toubia I; Nguyen C; Diring S; Onofre M; Daurat M; Gauthier C; Gary-Bobo M; Kobeissi M; Odobel F
Org Biomol Chem; 2023 Aug; 21(32):6509-6523. PubMed ID: 37341568
[TBL] [Abstract][Full Text] [Related]
13. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.
Narsireddy A; Vijayashree K; Adimoolam MG; Manorama SV; Rao NM
Int J Nanomedicine; 2015; 10():6865-78. PubMed ID: 26604753
[TBL] [Abstract][Full Text] [Related]
16. Mixed-Generation PAMAM G3-G0 Megamer as a Drug Delivery System for Nimesulide: Antitumor Activity of the Conjugate Against Human Squamous Carcinoma and Glioblastoma Cells.
Zaręba M; Sareło P; Kopaczyńska M; Białońska A; Uram Ł; Walczak M; Aebisher D; Wołowiec S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31601050
[TBL] [Abstract][Full Text] [Related]
17.
Wei X; Liu Z; Zhao Z
Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
19. Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment.
Wang Y; Zheng K; Xuan G; Huang M; Xue J
Int J Nanomedicine; 2018; 13():7681-7695. PubMed ID: 30538452
[TBL] [Abstract][Full Text] [Related]
20. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
